Form 4 for TMO Thermo Fisher Scientific

Accepted 2024-02-26 00:00:00 ET · period of report 2024-02-23 · accession 0001127602-24-006820 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2024-02-26	2024-02-23	TMO	Boxer Michael A	SVP, GC	F - Tax	$564.71	-239.82	13.4K	-2%	-$135.4K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-02-23	F	D	239.82	$564.71	13,374.24	D	—	—	(F1) Reflects a downward adjustment of 88 shares of a performance-based restricted stock unit award granted on February 23, 2021. On February 23, 2022, the reporting person reported the acquisition of the performance-based restricted stock unit award. One-third of the shares vested on February 23, 2022, one-third of the shares vested on February 23, 2023, and the remaining one-third vested on February 23, 2024, subject to adjustment based on the Company's relative total shareholder return ("TSR") over the measurement period starting on January 1, 2021, through to December 31, 2023. As a result of the Company's relative TSR, the third tranche was adjusted downward by 15%. As such, the reporting person received 88 less shares than the amount initially reported.